144 related articles for article (PubMed ID: 10297666)
1. Copayment for pharmaceutical services in a Medicaid program.
Nelson AA; Quick MR
Contemp Pharm Pract; 1980; 3(1):37-42. PubMed ID: 10297666
[TBL] [Abstract][Full Text] [Related]
2. The effect of a Medicaid drug copayment program on the utilization and cost of prescription services.
Nelson AA; Reeder CE; Dickson WM
Med Care; 1984 Aug; 22(8):724-36. PubMed ID: 6433121
[TBL] [Abstract][Full Text] [Related]
3. The differential impact of copayment on drug use in a Medicaid population.
Reeder CE; Nelson AA
Inquiry; 1985; 22(4):396-403. PubMed ID: 2934334
[TBL] [Abstract][Full Text] [Related]
4. Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.
Soumerai SB; Avorn J; Ross-Degnan D; Gortmaker S
N Engl J Med; 1987 Aug; 317(9):550-6. PubMed ID: 3302713
[TBL] [Abstract][Full Text] [Related]
5. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.
Hartung DM; Carlson MJ; Kraemer DF; Haxby DG; Ketchum KL; Greenlick MR
Med Care; 2008 Jun; 46(6):565-72. PubMed ID: 18520310
[TBL] [Abstract][Full Text] [Related]
6. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
Liu SZ; Romeis JC
Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
[TBL] [Abstract][Full Text] [Related]
7. Capitation payment for pharmacy services. I. Impact on drug use and pharmacist dispensing behavior.
Yesalis CE; Lipson DP; Norwood GJ; Helling DK; Burmeister LF; Jones ME; Fisher WP
Med Care; 1984 Aug; 22(8):737-45. PubMed ID: 6381921
[TBL] [Abstract][Full Text] [Related]
8. Pharmacists' views of an experience in capitation reimbursement under the Iowa Medicaid drug program.
Cirn JT
Contemp Pharm Pract; 1980; 3(3):180-8. PubMed ID: 10297946
[TBL] [Abstract][Full Text] [Related]
9. The tripartite reimbursement incentive model: a new method to eliminate the discounting of the copayment charge.
Paul SH
Med Mark Media; 1981 Mar; 16(3):35-9. PubMed ID: 10298125
[No Abstract] [Full Text] [Related]
10. Consumer attitudes and factors related to prescription switching decisions in multitier copayment drug benefit plans.
Ganther-Urmie JM; Nair KV; Valuck R; McCollum M; Lewis SJ; Turpin RS
Am J Manag Care; 2004 Mar; 10(3):201-8. PubMed ID: 15032257
[TBL] [Abstract][Full Text] [Related]
11. Consumer response to dual incentives under multitiered prescription drug formularies.
Gilman BH; Kautter J
Am J Manag Care; 2007 Jun; 13(6 Pt 2):353-9. PubMed ID: 17567236
[TBL] [Abstract][Full Text] [Related]
12. Who cares what it costs to dispense a Medicaid prescription?
Lamphere-Thorpe JA; Johnston WP; Kilpatrick KE; Norwood GJ
Health Care Financ Rev; 1994; 15(3):9-24. PubMed ID: 10137800
[TBL] [Abstract][Full Text] [Related]
13. Effect of copayments on drug use in the presence of annual payment limits.
Kephart G; Skedgel C; Sketris I; Grootendorst P; Hoar J
Am J Manag Care; 2007 Jun; 13(6 Pt 2):328-34. PubMed ID: 17567233
[TBL] [Abstract][Full Text] [Related]
14. Copayments for medications after June 30, 2010. Final rule.
Department of Veterans Affairs
Fed Regist; 2011 Feb; 76(35):9646-8. PubMed ID: 21351679
[TBL] [Abstract][Full Text] [Related]
15. Chronic Health Outcomes and Prescription Drug Copayments in Medicaid.
Kostova D; Fox J
Med Care; 2017 May; 55(5):520-527. PubMed ID: 28234755
[TBL] [Abstract][Full Text] [Related]
16. The elimination of selected drug products from the Michigan Medicaid formulary: a case study.
Smith DM; McKercher PL
Hosp Formul; 1984 May; 19(5):366-72. PubMed ID: 10299510
[TBL] [Abstract][Full Text] [Related]
17. Repackaged pharmaceuticals in the California workers' compensation system: from distribution and pricing options to physician and retail dispensing.
Gitlin M; Wilson L
Am J Ind Med; 2007 Apr; 50(4):303-15. PubMed ID: 17370319
[TBL] [Abstract][Full Text] [Related]
18. Medicaid program; prescription drugs. Final rule with comment period.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2007 Jul; 72(136):39141-245. PubMed ID: 17674494
[TBL] [Abstract][Full Text] [Related]
19. Modeling the potential impact of a prescription drug copayment increase on the adult asthmatic medicaid population.
Bae SJ; Paltiel AD; Fuhlbrigge AL; Weiss ST; Kuntz KM
Value Health; 2008; 11(1):110-8. PubMed ID: 18237365
[TBL] [Abstract][Full Text] [Related]
20. Copayments for medications in 2012. Final rule.
Department of Veterans Affairs
Fed Regist; 2012 May; 77(93):28258-9. PubMed ID: 22606731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
